Interleukin-6 and risk of cognitive decline: Macarthur studies of successful aging

Neurology

Volumn 59, Issue 3, 2002, Pages 371-378

  Weaver, J D ^a   Huang, M H ^a   Albert, M ^b   Harris, T ^c   Rowe, J W ^d   Seeman, T E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

AGED; AGING; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK; SOCIAL STATUS;

EID: 0037072285     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.3.371     Document Type: Article

References (26)

1. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain
2. Circulating cytokines in Alzheimer's disease
3. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease
4. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6
5. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on Successful Aging
6. Established populations for epidemiologic studies of the elderly: Study design and methodology
7. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients
8. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
9. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease
10. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome
11. A new rating scale for Alzheimer's disease
12. Cognitive performance in a high-functioning community-dwelling elderly population
13. Predicting changes in physical performance in a high functioning elderly cohort: MacArthur Studies of Successful Aging
14. Predictors of cognitive change in older persons: MacArthur Studies of Successful Aging
15. Serum IL-6 level and the development of disability in older persons
16. A survey for assessing physical activity among older adults
17. Effects of whole blood storage on results for glycosylated hemoglobin as measured by ion-exchange chromatography, affinity chromatography, and colorimetry
18. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6
19. NMDA receptor antagonists block norepinephrine-induced long-lasting potentiation and long-term potentiation in rat dentate gyrus
20. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells
21. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease
22. Interleukin-1 and the immunogenetics of Alzheimer disease
23. Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system
24. Passage of cytokines across the blood-brain barrier